PERIOPERATIVE MANAGEMENT IN CRANIOTOMY PATIENTS ON ANTIPLATELET AND ANTICOAGULANT THERAPY: A CROSS-SECTIONAL STUDY AT A TERTIARY CARE HOSPITAL IN PAKISTAN
DOI:
https://doi.org/10.69723/njms.04.02.0573Keywords:
Antiplatelet, Anticoagulants, Craniotomy, PerioperativeAbstract
BACKGROUND: The perioperative period, comprises the time before and after surgery, with a range from one week before surgery to four weeks following it. The five weeks are marked by occurrences during which most thrombotic and bleeding complications associated with perioperative antithrombotic management take place. Management of these risks presents a clinical challenge, particularly in neurosurgical procedures such as craniotomy due to high hemorrhagic potential of the procedure.
OBJECTIVE: To evaluate perioperative management strategies and associated complications in patients undergoing craniotomy while receiving antiplatelet and anticoagulant therapy.
METHODOLOGY: This is a cross-sectional study, conducted on 300 craniotomy patients over two years from 1st February 2022 till 1st January 2024 at the Irfan General Hospital, Peshawar. Patients aged 20 years and older receiving antiplatelet (aspirin, clopidogrel) or anticoagulant therapy (VKA, DOACs, and LMWH) were included. Data collection focused on patients’ demographics, perioperative management strategies, and post-op complications. SPSS software was used to analyze the data.
RESULTS: Among 300 patients, 195 (65%) received AP therapy, while 105(35%) were on AC therapy. Aspirin (36.7%) and clopidogrel (28.3%) were commonly used AP drugs. Whereas, VKA (18.3%) was primarily an AC drug. Perioperative management strategies varied, with 35% of patients temporarily discontinuing anticoagulants, 25% receiving bridging therapy with heparin, and 10% switching to LMWH. In AP therapy, minimal bleeding was observed in most patients (96, 49.2%), while in AC therapy, moderate bleeding was noticed at a greater rate of 38, 35.2%) indicating a significant difference in bleeding severity (p < 0.01).
CONCLUSION: This study highlights the prevalence of antithrombotic therapy among craniotomy patients and enhances the importance of individualized perioperative management to minimize complications. Temporary discontinuation and bridging strategies are some of the perioperative techniques commonly used.
KEYWORDS: Antiplatelet, Anticoagulants, Craniotomy, Perioperative.
References
Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, et al. Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline. Chest. 2022 Nov 1;162(5):e207–43. https://doi.org/10.1016/j.chest.2022.07.025
Tschan SL, Bolliger D. Coagulation and aging: implications for the anesthesiologist. Curr Anesth Rep. 2021. Epub ahead of print. https://doi.org/10.1007/s40140-021-00498-7
Shah SJ, Singer DE, Fang MC, Reynolds K, Go AS, Eckman MH. Net clinical benefit of oral anticoagulation among older adults with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2019;12:e006212. https://doi.org/10.1161/CIRCOUTCOMES.119.006212
Santana DC, Hadad MJ, Emara A, Klika AK, Barsoum W, Molloy RM, et al. Perioperative management of chronic antithrombotic agents in elective hip and knee arthroplasty. Medicina (Kaunas). 2021 Feb 23;57(2):188. https://doi.org/10.3390/medicina57020188
Boschitz D, Fastowiec DM, Bolliger D. Update on perioperative antithrombotic management. Curr Anesth Rep. 2024 May 15:1–0. https://doi.org/10.1007/s40140-021-00511-z
Prior A, Fiaschi P, Iaccarino C, Stefini R, Battaglini D, Balestrino A, et al. How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH). BMC Neurol. 2021 Dec;21:1–4. https://doi.org/10.1186/s12883-021-02126-7
Bolliger D, Lancé MD, Siegemund M. Point-of-care platelet function monitoring: implications for patients with platelet inhibitors in cardiac surgery. J Cardiothorac Vasc Anesth. 2021 Apr 1;35(4):1049–59. https://doi.org/10.1053/j.jvca.2020.07.050
Turcato G, Zaboli A, Zannoni M, Ricci G, Zorzi E, Ciccariello L, et al. Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants. Am J Emerg Med. 2021 May 1;43:180–5. https://doi.org/10.1016/j.ajem.2020.02.046
Yang Q, Zyck SA, Gould G, Gorji R, Li F. Management of patients on anticoagulants and antiplatelets in neurosurgery. In: Transfusion Practice in Clinical Neurosciences. Singapore: Springer Nature Singapore; 2022 Jun 17. p. 455–67. https://doi.org/10.1007/978-981-19-0954-2_40
Greuter L, Rychen J, Chiappini A, Mariani L, Guzman R, Soleman J. Management of patients undergoing elective craniotomy under antiplatelet or anticoagulation therapy: an international survey of practice. J Neurol Surg A Cent Eur Neurosurg. 2024 May;85(03):246–53. https://doi.org/10.1055/s-0043-1767724
Greuter L, Ullmann M, Mariani L, Guzman R, Soleman J. Effect of preoperative antiplatelet or anticoagulation therapy on hemorrhagic complications in patients with traumatic brain injury undergoing craniotomy or craniectomy. Neurosurg Focus. 2019 Nov 1;47(5):E3. https://doi.org/10.3171/2019.8.FOCUS19546
Ebel F, Ullmann M, Guzman R, Soleman J. Does the discontinuation time of antiplatelet or anticoagulation treatment affect hemorrhagic complications in patients undergoing craniotomy for neurovascular lesions? Br J Neurosurg. 2021 Sep 3;35(5):619–24. https://doi.org/10.1080/02688697.2021.1929835
Rychen J, Saemann A, Fingerlin T, Guzman R, Mariani L, Greuter L, et al. Risks and benefits of continuation and discontinuation of aspirin in elective craniotomies: a systematic review and pooled-analysis. Acta Neurochir (Wien). 2023 Jan;165(1):39–47. https://doi.org/10.1007/s00701-022-05416-2
Gotoh S, Yasaka M, Nakamura A, Kuwashiro T, Okada Y. Management of antithrombotic agents during surgery or other kinds of medical procedures with bleeding: the MARK study. J Am Heart Assoc. 2020 Mar 3;9(5):e012774. https://doi.org/10.1161/JAHA.119.012774
Zhang JJ, Aw NM, Tan CH, Lee KS, Chen VH, Wang S, et al. Impact of time to resumption of antithrombotic therapy on outcomes after surgical evacuation of chronic subdural hematoma: a multicenter cohort study. J Clin Neurosci. 2021 Jul 1;89:389–96. https://doi.org/10.1016/j.jocn.2021.05.036
Riviere-Cazaux C, Naylor RM, Van Gompel JJ. Ultra-early therapeutic anticoagulation after craniotomy–a single institution experience. J Clin Neurosci. 2022 Jun 1;100:46–51. https://doi.org/10.1016/j.jocn.2022.03.042
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Amina Sultan, Lubna Naz, Haseena sabir, Rahida, Mushafa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
